Industry
What The AKA's GMP 4.0 Standard Requires, And What Changed From The Version Before It

Disclosure: The Kratom Council is owned by NWB Distribution LP, which also operates the kratom retailer NuWave Botanicals. NuWave Botanicals is an AKA GMP Qualified Vendor and was audited under the standard described below. This article describes the program. It does not rank or recommend any vendor.
The American Kratom Association runs the only industry-wide manufacturing standard for kratom in the United States. Its fourth version, GMP 4.0, took effect on January 1, 2025. Vendors move onto it at their annual renewal, which means most of the companies on the AKA's public list are going through their first 4.0 audits now.
The program is voluntary. No federal or state law requires a kratom vendor to join it. What it offers shoppers is a public list of companies that have opened their facilities to an outside auditor. What follows is what that audit checks, what 4.0 added, and what the listing does and does not mean.
The Manufacturing Rules Come From Federal Supplement Law
The AKA's program document states that the scope of its manufacturing requirements is based on 21 C.F.R. Part 111, the Food and Drug Administration's Current Good Manufacturing Practice rule for the manufacturing, packaging, labeling and holding of dietary supplements. The program is explicit that a participant's products do not have to be dietary supplements. The federal rule is used as the yardstick.
That rule reaches personnel and hygiene, the physical plant and grounds, equipment and utensils, written procedures, production and process controls, laboratory operations, batch records, packaging and labeling operations, holding and distribution, and complaint handling. Participants only have to meet the parts that apply to the work they actually do, since a single kratom product can pass through an importer, a processor, a packager and a retailer.
On this core, the audit checklist carried over from the previous version, GMP 3.0, with renumbering and reformatting and no substantive change to the Part 111 requirement tables. The changes in 4.0 sit around that core.
What GMP 4.0 Added
Release testing on every finished product
The 4.0 program document states that all final products must be tested, prior to release, to confirm they are not contaminated with pesticides, heavy metals or microbes that would cause the product to be adulterated.
A label standard modeled on the Kratom Consumer Protection Act
The AKA publishes a separate 4.0 labeling document, which it says is largely based on its model Kratom Consumer Protection Act. It requires every retail package to carry, clearly and conspicuously:
- a recommendation against use by anyone under 18, pregnant or breastfeeding
- a recommendation to consult a health care professional before use
- a statement that kratom may be habit forming
- the standard FDA disclaimer that the statements have not been evaluated and the product is not intended to diagnose, treat, cure or prevent any disease
- the name and business address of the processor, distributor or retailer responsible for the product
- a recommended serving, a recommended maximum number of servings in 24 hours, and servings per container
- a listing of kratom alkaloids and other ingredients, including a quantitative not-to-exceed declaration of mitragynine per serving
Kratom beverages prepared on-site must carry the same information on a card or a sign at the point of sale. Products that contain other permitted psychoactive compounds must disclose every active ingredient, the exact concentration of each and warnings about combined use.
The 2 percent line on 7-OH
The most consequential sentence in the labeling document concerns 7-hydroxymitragynine, the alkaloid at the center of this year's federal and state enforcement. Labels must declare that 7-OH does not exceed 2 percent of the product's overall alkaloid composition. The document then states that any product above that limit cannot be marketed or labeled as kratom, and cannot reference kratom anywhere on its packaging.
That is a definition, not just a label rule. Within the AKA program, a concentrated or synthetic 7-OH product is not a kratom product. The line arrives as federal regulators draw one of their own. On October 14 the Drug Enforcement Administration published a new notice of intent, following a recommendation from the Department of Health and Human Services, to temporarily schedule 7-OH and mitragynine pseudoindoxyl above a threshold, and withdrew the proposal it had issued in July. Cities and states, meanwhile, keep writing rules of their own. Some of those local rules draw a distinction between kratom leaf and concentrated 7-OH. Others do not.
A written eight-step certification path
4.0 sets out the certification process in order: application and annual fee, an orientation call and pre-audit preparation, an auditor questionnaire and document request, auditor review and feedback with any corrective actions, an on-site audit by a third-party auditor, the auditor's gap analysis and score, review of the results by the AKA, and certification. The program describes the process as collaborative and phased, with feedback to the applicant along the way.
The AKA's program page adds the operating rules. Every auditor and testing laboratory must be pre-approved by the AKA. A vendor has 90 days from registration to complete its audit. The AKA reviews each audit report within three business days and makes the final determination. Qualified status lasts one year and has to be renewed with a new passing audit. The AKA reserves the right to remove or suspend a vendor for failing to maintain the standards, pay the annual fee, submit an annual audit from an approved auditor or correct audit findings, or for multiple reports of adverse events tied to its products.
An on-ramp for FDA-registered food facilities
Facilities that are registered with the FDA as food facilities and have been inspected may use that status as an alternative form of initial certification. They remain subject to everything else in the program, including periodic audits, product testing and labeling reviews.
What The Listing Does Not Mean
The 4.0 document is unusually direct about its own limits. It states that the program does not certify the safety of any kratom product, and that safety is the responsibility of the manufacturer. It states that a listing as an AKA GMP Qualified Vendor is not an endorsement by the AKA of any manufacturer or of any specific product, only that the facility adhered to GMP requirements, and that participants may not suggest otherwise. It also states that participation does not replace federal, state or local law, and does not protect a vendor from regulatory action.
The AKA's program page puts it in one line: certification "represents facility and process certification versus product certification." A listed vendor may not represent anything beyond having passed an independent third-party audit showing it complies with the program.
For a shopper, that makes the listing a narrow and useful fact. A listed company has let an outside auditor inspect how it makes, tests, labels and stores what it sells, and has agreed to the label rules above. The listing does not say anything about what a product does.
The short description that appears beside each company on the AKA's list is supplied by that company, not written by the AKA or its auditors. It is not part of what the audit verifies. The listing itself is the fact the audit stands behind.
How To Use The Program As A Shopper
- Check the company's name against the AKA's public GMP Qualified Vendor list.
- Read the label for a mitragynine amount per serving and a 7-OH declaration at or under 2 percent of total alkaloids.
- Look for the name and street address of a responsible business, an age statement and the required warnings.
- Ask for the batch certificate of analysis. Release testing under 4.0 means one should exist for every finished lot.
- Treat a package that advertises 7-OH content as a selling point as a product the AKA program does not consider kratom.
Sources
- American Kratom Association — GMP Standards Program
- American Kratom Association — GMP 4.0 Labeling Requirements
- American Kratom Association — GMP Qualified Vendors
- Electronic Code of Federal Regulations — 21 C.F.R. Part 111
- Federal Register — DEA notice of intent, 7-hydroxymitragynine and mitragynine pseudoindoxyl above a specified threshold (October 14, 2026)
Get new reporting by email
Federal and state kratom policy, enforcement actions and court decisions — sent when we publish, and nothing else.
The Kratom Council does not sell kratom. This list is used only to send our own articles — never product marketing, and it is never shared with or merged into any retailer’s mailing list. Unsubscribe any time.
